公开(公告)号：US20100229117A1

公开(公告)日：2010-09-09

申请号：US12703902

申请日：2010-02-11

Applicant: Chang Woo LEE ,  Won Kyung SEONG

Inventor： Chang Woo LEE ,  Won Kyung SEONG

IPC: G06F9/00 ,  G06F3/048

CPC classification number: G06F3/0482 ,  G06F9/4418 ,  G06F9/442 ,  H04M1/72563 ,  H04M1/72583 ,  H04M2250/22

Abstract: Provided is a method of displaying information of a portable device, which includes receiving a signal of booting or termination of the portable device; and displaying a valid information which is previously set while the booting or termination process is performing.

Abstract translation: 提供了一种显示便携式设备的信息的方法，其包括接收便携式设备的启动或终止信号; 并显示在启动或终止处理正在执行时预先设置的有效信息。

公开(公告)号：US20170239259A1

公开(公告)日：2017-08-24

申请号：US14569201

申请日：2014-12-12

Applicant: Kyeong LEE ,  Mi Sun WON ,  Hwan Mook KIM ,  Song Kyu PARK ,  Kiho LEE ,  Ki Hoon LEE ,  Chang Woo LEE ,  Jung Joon LEE ,  Kyung Sook CHUNG ,  Bo Kyung KIM ,  Yinglan JIN ,  Seung-hee LEE

Inventor： Kyeong LEE ,  Mi Sun WON ,  Hwan Mook KIM ,  Song Kyu PARK ,  Kiho LEE ,  Ki Hoon LEE ,  Chang Woo LEE ,  Jung Joon LEE ,  Kyung Sook CHUNG ,  Bo Kyung KIM ,  Yinglan JIN ,  Seung-hee LEE

IPC: A61K31/5375 ,  A61K31/167 ,  A61K31/196 ,  A61K31/40 ,  A61K31/34 ,  A61K9/08 ,  A61K31/417 ,  A61K9/00 ,  A61K9/14 ,  A61K9/20 ,  A61K9/48 ,  A61K31/24 ,  A61K31/4409

CPC classification number: A61K31/5375 ,  A61K9/0019 ,  A61K9/08 ,  A61K9/14 ,  A61K9/20 ,  A61K9/48 ,  A61K31/167 ,  A61K31/196 ,  A61K31/24 ,  A61K31/34 ,  A61K31/40 ,  A61K31/417 ,  A61K31/4409 ,  C07C233/07 ,  C07C235/28 ,  C07C311/16 ,  C07C311/46 ,  C07C317/40 ,  C07C2603/74 ,  C07D295/088

Abstract: The present invention relates to a compound inhibiting HF-1 activity, a preparation method of the same, and a pharmaceutical composition comprising the same as an active ingredient. The compound of the present invention demonstrates anticancer activity not by non-selective cytotoxicity but by inhibiting the activity of HIF-1, the transcription factor playing an important role in cancer cell growth and metastasis.Accordingly, the compound or the pharmaceutically acceptable salt thereof according to the present invention inhibits HIF-1 activity, and therefore can be used as a therapeutic agent for solid tumors such as colon cancer, liver cancer, stomach cancer and breast cancer. In addition, the compound or the pharmaceutically acceptable salt thereof according to the present invention can be used as an active ingredient for a therapeutic agent for diabetic retinopathy or arthritis which may become worse when hypoxia-induced VEGF expression by HIF-1 increases.

公开(公告)号：US20170148678A1

公开(公告)日：2017-05-25

申请号：US15423602

申请日：2017-02-03

Applicant: Sehoon Yoo ,  Chang Woo LEE ,  Jun Ki KIM ,  Jeong Han KIM ,  Young Ki KO

Inventor： Sehoon Yoo ,  Chang Woo LEE ,  Jun Ki KIM ,  Jeong Han KIM ,  Young Ki KO

IPC: H01L21/768 ,  B23K1/00 ,  B23K3/06 ,  H01L23/48

CPC classification number: H01L21/76898 ,  B23K1/0016 ,  B23K1/20 ,  B23K3/06 ,  B23K3/0646 ,  B23K3/087 ,  B23K2101/40 ,  H01L23/481

Abstract: A wafer via solder filling device includes a solder bath comprising an accommodation space for accommodating a molten solder, with an open top, and an air outlet for exhausting air from the accommodation space; a fixing unit for fixing the wafer having a via formed in one surface in the accommodation space to seal the accommodation space airtight; and a pressing unit for pressing a bottom of the molten solder arranged in the solder bath and moving the molten solder upward, to fill the molten solder in the via.

公开(公告)号：US20100286207A1

公开(公告)日：2010-11-11

申请号：US12839874

申请日：2010-07-20

Applicant: Yung Hee KHO ,  Gyoon Hee HAN ,  Ho Jae LEE ,  Bum Woo PARK ,  Hyo Kon CHUN ,  Hwan Mook KIM ,  Song Kyu PARK ,  Sang Bae HAN ,  Dong Kyu RYU ,  Tae Gyu CHUN ,  Jin Ha LEE ,  Chang Woo LEE ,  Ki Hoon LEE ,  Hee Yoon LEE

Inventor： Yung Hee KHO ,  Gyoon Hee HAN ,  Ho Jae LEE ,  Bum Woo PARK ,  Hyo Kon CHUN ,  Hwan Mook KIM ,  Song Kyu PARK ,  Sang Bae HAN ,  Dong Kyu RYU ,  Tae Gyu CHUN ,  Jin Ha LEE ,  Chang Woo LEE ,  Ki Hoon LEE ,  Hee Yoon LEE

IPC: A61K31/4436 ,  A61P29/00 ,  A61P19/02 ,  C07D207/38 ,  A61K31/4015 ,  C07D409/06 ,  A61K31/4025 ,  A61K31/4412 ,  C07D211/86

CPC classification number: C07D207/26 ,  C07D207/38 ,  C07D211/86 ,  C07D409/06

Abstract: The present invention is related to new 2-oxo-cyclic compound, the process for preparing them and a pharmaceutical composition comprising the same. The present invention provides a pharmaceutical composition for preventing and treating the inflammatory disease comprising the pain or inflammation caused by rheumatic disease, for example, rheumatoid arthritis, spondyloarthopathies, gout, osteoarthritis, systemic lupus erythematosus and juvenile arthritis, and inflammatory syndrome for example, from myositis, gingivitis, synovitis, ankylosing spondylitis, burstitis, burns and scar, inflammatory Crohn's disease, Types I diabetes. therefore, it can be used as the therapeutics for treating and preventing inflammatory diseases.

Abstract translation: 本发明涉及新的2-氧代环状化合物，其制备方法和包含其的药物组合物。 本发明提供了用于预防和治疗炎性疾病的药物组合物，其包括由风湿性疾病引起的疼痛或炎症，例如类风湿性关节炎，脊椎动物病变，痛风，骨关节炎，系统性红斑狼疮和幼年关节炎以及炎性综合征，例如， 肌炎，牙龈炎，滑膜炎，强直性脊柱炎，爆发性炎症，烧伤和瘢痕，炎性克罗恩病，I型糖尿病。 因此，它可以用作治疗和预防炎性疾病的治疗剂。